Mark Newton, a consultant from Heartland QA, gives his take on the scale of research misconduct taking place in laboratories
Dr Alexander Jarasch and Professor Martin Hrabe de Angelis explain that novel research methods produce tremendous amounts of data that cannot be analysed with classic analysis tools – so scientists need to look for new approaches, such as graph technology
Darren Barrington-Light, senior manager product marketing for Thermo Fisher Scientific, explains the importance of integrating a LIMS software package into the pharmaceutical data chain
Robert Roe talks to laboratory software providers about their plans for the future of the laboratory
Robert Roe speaks with laboratory informatics software providers about the future of their software and the introduction of new technologies, such as AI and deep learning
Robert Roe looks at regulatory and technological changes that are changing the way drug development is carried out
As not only the HPC industry but the larger computing ecosystem tries to overcome the slowdown and eventual end of transistor scaling described by Moore’s Law, scientists and researchers are implementing programmes that will define the technologies and new materials needed to supplement, or repla
Architectural specialisation is one option to continue to improve performance beyond the limits imposed by the slow down in Moore’s Law.
As the complexity of both HPC hardware and the challenges that scientists are trying to solve using HPC systems increases, ensuring a system is utilised efficiently is necessary to deliver a computing service with value for money and a high research output.
With data rates increasing and more complex challenges arising in life sciences, Panasas’ Jim Donovan and Dale Brantly discuss the benefits of using HPC for these workloads
